Midlife hypertensive status and cognitive function 20 years later: The Southall and Brent revisited study

Journal of the American Geriatrics Society

Volumn 61, Issue 9, 2013, Pages 1489-1498

  Taylor, Clare ^a   Tillin, Therese ^b   Chaturvedi, Nish ^b   Dewey, Michael ^a   Ferri, Cleusa P ^a,c   Hughes, Alun ^b   Prince, Martin ^a   Richards, Marcus ^d   Shah, Ajit ^e   Stewart, Robert ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

ambulatory blood pressure; blood pressure; cognitive impairment; hypertension; pulse pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AFRICAN CARIBBEAN; AGED; ARTICLE; ASIAN; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CAUCASIAN; COGNITION; COGNITIVE DEFECT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PULSE RATE; SYSTOLIC BLOOD PRESSURE;

AMBULATORY BLOOD PRESSURE; BLOOD PRESSURE; COGNITIVE IMPAIRMENT; HYPERTENSION; PULSE PRESSURE;

ADULT; AGED; BLOOD PRESSURE; COGNITION; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; FORECASTING; HUMANS; HYPERTENSION; LONDON; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; URBAN POPULATION;

EID: 84884279789     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12416     Document Type: Article

References (42)

1. Qiu C, Winblad B, Fratiglioni L,. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005; 4: 487-499.
2. Elias MF, Wolf PA, D'Agostino RB, et al. Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study. Am J Epidemiol 1993; 138: 353-364.
3. Kilander L, Nyman H, Boberg M, et al. Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men. Hypertension 1998; 31: 780-786.
4. Kivipelto M, Helkala EL, Hanninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 2001; 56: 1683-1689.
5. Launer LJ, Masaki K, Petrovitch H, et al. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995; 274: 1846-1851.
6. Swan GE, Carmelli D, Larue A,. Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. Stroke 1998; 29: 2334-2340.
7. de Simone G, Roman MJ, Alderman MH, et al. Is high pulse pressure a marker of preclinical cardiovascular disease? Hypertension 2005; 45: 575-579.
8. Qiu C, Winblad B, Viitanen M, et al. Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: A community-based, longitudinal study. Stroke 2003; 34: 594-599.
9. Waldstein SR, Rice SC, Thayer JF, et al. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension 2008; 51: 99-104.
10. Yasar S, Ko JY, Nothelle S, et al. Evaluation of the effect of systolic blood pressure and pulse pressure on cognitive function: The Women's Health and Aging Study II. PLoS One 2011; 6: e27976.
11. Ghuman N, Campbell P, White WB,. Role of ambulatory and home blood pressure recording in clinical practice. Curr Cardiol Rep 2009; 11: 414-421.
12. White WB, Wolfson L, Wakefield DB, et al. Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people. Circulation 2011; 124: 2312-2319.
13. Yudkin JS, Forrest RD, Jackson CA,. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988; 8610: 530-533.
14. Tillin T, Forouhi NG, McKeigue PM, et al. Southall And Brent REvisited: Cohort profile of SABRE, a UK population-based comparison of cardiovascular disease and diabetes in people of European, Indian Asian and African Caribbean origins. Int J Epidemiol 2012; 41: 33-42.
15. Elliott P, Stamler R,. Manual of operations for "INTERSALT", an international cooperative study on the relation of sodium and potassium to blood pressure. Control Clin Trials 1988; 9 (2 Suppl): 1S-117S.
16. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications (Contract No. WHO/NCD/NCS/99.2). Geneva, Switzerland: World Health Organization, 1999.
17. Tillin T, Forouhi N, McKeigue P, et al. Microalbuminuria and coronary heart disease risk in an ethnically diverse UK population: A prospective cohort study. J Am Soc Nephrol 2005; 16: 3702-3710.
18. Prince M, Acosta D, Chiu H, et al. Dementia diagnosis in developing countries: A cross-cultural validation study. Lancet 2003; 9361: 909-917.
19. Stewart R, Richards M, Brayne C, et al. Vascular risk and cognitive impairment in an older, British, African-Caribbean population. J Am Geriatr Soc 2001; 49: 263-269.
20. Hall KS, Hendrie HC, Rodgers DD, et al. The development of a dementia screening interview in two distinct languages. Int J Methods Psychiatr Res 1993; 3: 1-28.
21. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39: 1159-1165.
22. Goodglass H, Kaplan D,. The Assessment of Dysphasia and Related Disorders. Philadelphia, PA: Lea and Febinger, 1983.
23. Lee TM, Cheung CC, Chan JK, et al. Trail making across languages. J Clin Exp Neuropsychol 2000; 22: 772-778.
24. Weschler D,. Weschler Memory Scale-Revised Manual. San Antonio, TX: Psychological Corporation, 1987.
25. World Health Organization. Report of a Consultation on Development of a WHO/MNH Battery of Cognitive Assessment Instruments. Geneva, Switzerland: World Health Organization, 1993.
26. Elias PK, Elias MF, D'Agostino RB, et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 1997; 20: 1388-1395.
27. Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011; 77: 461-468.
28. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: The Honolulu-Asia Aging Study. Neurobiol Aging 2000; 21: 49-55.
29. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. BMJ 2001; 322: 1447-1451.
30. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.
31. Freitag MH, Peila R, Masaki K, et al. Midlife pulse pressure and incidence of dementia: The Honolulu-Asia Aging Study. Stroke 2006; 37: 33-37.
32. Nagai M, Hoshide S, Kario K,. Hypertension and dementia. Am J Hypertens 2010; 23: 116-124.
33. Kanemaru A, Kanemaru K, Kuwajima I,. The effects of short-term blood pressure variability and nighttime blood pressure levels on cognitive function. Hypertens Res 2001; 24: 19-24.
34. Yamamoto Y, Akiguchi I, Oiwa K, et al. The relationship between 24-hour blood pressure readings, subcortical ischemic lesions and vascular dementia. Cerebrovasc Dis 2005; 19: 302-308.
35. Sakakura K, Ishikawa J, Okuno M, et al. Exaggerated ambulatory blood pressure variability is associated with cognitive dysfunction in the very elderly and quality of life in the younger elderly. Am J Hypertens 2007; 20: 720-727.
36. Di Bari M, Pahor M, Franse LV, et al. Dementia and disability outcomes in large hypertension trials: Lessons learned from the Systolic Hypertension in the Elderly Program (SHEP) Trial. Am J Epidemiol 2001; 153: 72-78.
37. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 9137: 1347-1351.
38. Lithell H, Hansson L, Skoog I, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21: 875-886.
39. Prince MJ, Bird AS, Blizard RA, et al. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ 1996; 312: 801-805.
40. Starr JM, Whalley LJ, Deary IJ,. The effects of antihypertensive treatment on cognitive function: Results from the HOPE study. J Am Geriatr Soc 1996; 44: 411-415.
41. Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003; 163: 1069-1075.
42. Forette F, Seux ML, Staessen JA, et al. The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) Study. Arch Intern Med 2002; 162: 2046-2052.